Praxis Precision Medicines (PRAX) Accumulated Depreciation & Amortization (2019 - 2025)

Praxis Precision Medicines has reported Accumulated Depreciation & Amortization for 7 years, with the latest figure at $1.5 million in Q4 2025.

• For the quarter ending Q4 2025, Accumulated Depreciation & Amortization rose 10.2% year-over-year to $1.5 million; the trailing twelve-month figure through Dec 2025 stood at $1.5 million (up 10.2% YoY), and the FY2025 full-year result was $1.5 million, up 10.2% from the prior year.
• Accumulated Depreciation & Amortization for Q4 2025 stood at $1.5 million, up from $1.4 million in the prior quarter.
• The five-year high for Accumulated Depreciation & Amortization was $1.5 million in Q4 2025, with the low at $153000.0 in Q4 2021.
• Average Accumulated Depreciation & Amortization over 5 years is $919000.0, with a median of $1.0 million recorded in 2023.
• Year-over-year, Accumulated Depreciation & Amortization jumped 273.86% in 2022 and climbed 10.2% in 2025.
• Tracing PRAX's Accumulated Depreciation & Amortization over 5 years: stood at $153000.0 in 2021, then jumped by 273.86% to $572000.0 in 2022, then surged by 75.7% to $1.0 million in 2023, then surged by 35.62% to $1.4 million in 2024, then rose by 10.2% to $1.5 million in 2025.
• The last three Accumulated Depreciation & Amortization figures came in at $1.5 million (Q4 2025), $1.4 million (Q4 2024), and $1.0 million (Q4 2023), per Business Quant data.

Peer Comparison